(Q34416726)

English

Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Gillies HC

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Herriott D

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Liang R

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ohashi K

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Rogers HJ

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Harper PG

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 March 1987

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

303-310

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

A pharmacokinetic analysis program (multi) for microcomputer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386228

6 July 2018

Daunorubicin metabolism in acute nonlymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386228

6 July 2018

Properties of antitumor anthracyclines and new developments in their application: Cain memorial award lecture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386228

6 July 2018

Prediction of adriamycin disposition in cancer patients using a physiologic, pharmacokinetic model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386228

6 July 2018

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386228

6 July 2018

A review of carminomycin-a new anthracycline developed in the USSR

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386228

6 July 2018

Comparison of Biochemical and Biological Methods in the Evaluation of New Anthracycline Drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1386228

6 July 2018

Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of 4-demethoxydaunorubicin in patients with adenocarcinoma of the upper gastrointestinal tract

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and II clinical and pharmacological study of 4-demethoxydaunorubicin (idarubicin) in adult patients with acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 4-demethoxydaunorubicin in patients with non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity and distribution of iv and oral 4-demethoxydaunorubicin in murine experimental tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative pharmacokinetics and metabolism of doxorubicin and epirubicin in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of 4-demethoxydaunorubicin in patients with advanced malignant melanoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low dose oral administration of 4-demethoxydaunorubicin (idarubicin) in advanced cancer patients. A pharmacokinetic study

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of 4-demethoxydaunorubicin administered orally

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between effects on nucleic acid synthesis in cell cultures and cytotoxicity of 4-demethoxy derivatives of daunorubicin and adriamycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes of activity of daunorubicin, adriamycin and stereoisomers following the introduction or removal of hydroxyl groups in the amino sugar moiety

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I and clinical pharmacology study of intravenously administered carminomycin in cancer patients in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cellular and plasma kinetics of daunorubicin given by two methods of administration in a patient with acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time dependency of adriamycin and adriamycinol kinetics

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of 4-demethoxydaunorubicin with single i.v. doses

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3471265

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.1987.TB03049.X

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34416726&oldid=1619063055"